BTIG Reiterates Buy Rating on Protagonist Therapeutics (PTGX)

December 10, 2024 8:51 AM EST Send to a Friend
BTIG analyst Julian Harrison reiterated a Buy rating and $67.00 price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login